Cooper
Who owns Cooper?
Cooper is a British Pharma company, currently owned by CVC Capital Partners since 2021. It changed hands in 2021, when Charterhouse Capital Partners sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Held by CVC Capital Partners since 2021 (5Y hold).
- ·Best return: 3.0x MOIC by Charterhouse Capital Partners (2021 exit).
Ownership history
2 ownership periods
Charterhouse Capital Partners sold Cooper to CVC Capital Partners in 2021 after 6 years.
More from CVC Capital Partners Fund VII
Other portfolio companies in the same fund.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Questions
Who owns Cooper?
Cooper is currently owned by CVC Capital Partners, through CVC Capital Partners Fund VII, since 2021.
When did CVC Capital Partners acquire Cooper?
CVC Capital Partners acquired Cooper in 2021.
Who did Cooper sell to?
Charterhouse Capital Partners sold Cooper to CVC Capital Partners in 2021 (Secondary), 3.0x return.
Who has owned Cooper over time?
Cooper has been through 2 private-equity ownership periods: Charterhouse Capital Partners · via Charterhouse Capital Partners X · 2015–2021 · sold to CVC Capital Partners · (Secondary) · 3.0x; CVC Capital Partners · via CVC Capital Partners Fund VII · since 2021.